Even though controversial data exist on the prognostic role of Fas expression on cancer tissues [19,21,35], numerous studies converge on the adverse prognostic value of tumoral FasL expression in breast, lung, esophageal, and colorectal cancer tissues [22,23,36]. The gene discussed is FAS; the disease is colorectal cancer.